← Leaderboards
Michael R. Narkewicz
University Of Colorado Denver
$249,387
Attributed
$249,387
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $117.6K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$249,387 · 14
By mechanism
M01$249,387 · 14
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Sally P Stabler$1,782,834
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectSerumNutrition Related TagInstitutionFundingSourceUnited States National Institutes Of HealthResourcesGrantResearch PersonnelDietary Trace ElementComputer Retrieval Of Information On Scientific Projects DatabaseLiver Disorder DiagnosisChildPostoperative StateCystic FibrosisManganeseLongitudinal Human StudyMetal MetabolismLiver Failure, AcuteLaboratoriesLiver TransplantationBiomarker
Grant awards (19)
A MULTICENTER GROUP TO STUDY ACUTE LIVER FAILURE IN CHILDREN$76,347
M01 · FY2007 · RR · contact PI
FOLATE STATUS IN INTRAUTERINE GROWTH RETARDED INFANTS$20,929
M01 · FY2007 · RR · contact PI
PEGYLATED INTERFERON +/- RIBAVIRIN FOR CHILDREN WITH HCV$14,765
M01 · FY2007 · RR · contact PI
N-ACETYLCYSTEINE IN TREATMENT OF ACUTE LIVER FAILURE NOT CAUSE BY ACETAMINOPHEN$5,538
M01 · FY2007 · RR · contact PI
PEGYLATED INTERFERON +/- RIBAVIRIN FOR CHILDREN WITH HCV$31,324
M01 · FY2006 · RR · contact PI
FOLATE STATUS IN INTRAUTERINE GROWTH RETARDED INFANTS$10,937
M01 · FY2006 · RR · contact PI
A MULTICENTER GROUP TO STUDY ACUTE LIVER FAILURE IN CHILDREN$9,964
M01 · FY2006 · RR · contact PI
MAGNESIUM AND METABOLIC BONE DISEASE IN CHRONIC LIVER DISEASE$4,861
M01 · FY2006 · RR · contact PI
N-ACETYLCYSTEINE IN TREATMENT OF ACUTE LIVER FAILURE NOT CAUSE BY ACETAMINOPHEN$4,051
M01 · FY2006 · RR · contact PI
A MULTICENTER GROUP TO STUDY ACUTE LIVER FAILURE IN CHILDREN$22,529
M01 · FY2005 · RR
N-ACETYLCYSTEINE IN TREATMENT OF ACUTE LIVER FAILURE NOT CAUSE BY ACETAMINPHEN$2,422
M01 · FY2005 · RR
FOLATE STATUS IN INTRAUTERINE GROWTH RETARDED INFANTS$2,422
M01 · FY2005 · RR
Folate Status in Intrauterine Growth Retarded Infants$3,578
M01 · FY2004 · RR
EFFICACY OF SERUM BILE ACIDS IN DETERMINING HEPATOBILIARY DISEASE IN CF$0
M01 · FY2002 · RR
ZINC STATUS IN PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATION$0
M01 · FY2002 · RR
TAUROURSO DEOXYCHOLIC ACID IN CYSTIC FIBROSIS LIVER DISEASE$19,860
M01 · FY2000 · RR
PREVALENCE AND PATTERN OF HEPATIC DYSFUNCTION FOLLOWING FONTAN PROCEDURE$19,860
M01 · FY2000 · RR
ZINC STATUS IN PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATION$0
M01 · FY2000 · RR
EFFICACY OF SERUM BILE ACIDS IN DETERMINING HEPATOBILIARY DISEASE IN CF$0
M01 · FY2000 · RR